Lam Research Share Buybacks decreased by 24.5% to $975.79M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.1%, from $997.04M to $975.79M. Over 2 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 17.7% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $431.26M | $1.24B | $2.42B | $876.09M | $109.78M | $1.38B | $869.01M | $843.24M | $851.49M | $774.53M | $373.55M | $997.04M | $1.44B | $0.00 | $1.29B | $975.79M |
| QoQ Change | — | +186.8% | +96.0% | -63.9% | -87.5% | >999% | -37.0% | -3.0% | +1.0% | -9.0% | -51.8% | +166.9% | +44.9% | -100.0% | — | -24.5% |
| YoY Change | — | — | — | +103.1% | -91.1% | — | -0.8% | +668.1% | -38.2% | — | -57.0% | +18.2% | +69.7% | -100.0% | +245.9% | -2.1% |